Journals / İstanbul Medical Journal / 2013 / Cilt: 14 - Sayı: 2

Paraoxonase Activity and Oxidized LDL Levels as Cardiovascular Risk Factors in Patients with Coronary Artery Disease

Koroner Arter Hastalarında Kardiyovasküler Risk Faktörü Olarak Paraoksonaz Aktivitesi ve Okside LDL Düzeyleri

Pages
69–75
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

PON1 activity and TBARS levels were measured spectrophotometrically; Ox-LDL levels were determined by ELISA; ApoA1levels were determined immunoturbidometrically; and TC, TG, and HDL-C levels were determined enzymatically.Results: In the study we observed that PON1 activity decreases when the number of affected vessels increases (r=-0,537, p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of this study was to investigate the possible relationship between serum oxidized low-density lipoprotein (Ox-LDL) concentration, recently shown to be a cardiovascular risk factor, paraoxonase 1 (PON1) activity and Thiobarbituric Acid Reactive Substance (TBARS) levels, and the severity of Coronary Artery Disease (CAD) as determined by the obstructive vessel number inpatients.
📊
Key Findings & Data:Methods: We determined plasma PON1 activity, serum Ox-LDL concentration, Apolipoprotein A1 (ApoA1) levels, TBARS levels and lipid profiles, including total cholesterol (TC), triglycerides (TG), Low-Density Lipoprotein cholesterol (LDL-C), High-Density Lipoprotein cholesterol (HDL-C), and Very Low-Density Lipoprotein cholesterol (VLDL-C), in patients with CAD (n=42) and in a healthy control group (n=17).
💡
Conclusion & Impact:PON1 activity and TBARS levels were measured spectrophotometrically; Ox-LDL levels were determined by ELISA; ApoA1levels were determined immunoturbidometrically; and TC, TG, and HDL-C levels were determined enzymatically.Results: In the study we observed that PON1 activity decreases when the number of affected vessels increases (r=-0,537, p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The aim of this study was to investigate the possible relationship between serum oxidized low-density lipoprotein (Ox-LDL) concentration, recently shown to be a cardiovascular risk factor, paraoxonase 1 (PON1) activity and Thiobarbituric Acid Reactive Substance (TBARS) levels, and the severity of Coronary Artery Disease (CAD) as determined by the obstructive vessel number inpatients. Methods: We determined plasma PON1 activity, serum Ox-LDL concentration, Apolipoprotein A1 (ApoA1) levels, TBARS levels and lipid profiles, including total cholesterol (TC), triglycerides (TG), Low-Density Lipoprotein cholesterol (LDL-C), High-Density Lipoprotein cholesterol (HDL-C), and Very Low-Density Lipoprotein cholesterol (VLDL-C), in patients with CAD (n=42) and in a healthy control group (n=17). The CAD group was divided into three subgroups with single- (n=13), double- (n=15) and triple-vessel (n=14) disease according to their angiography results. PON1 activity and TBARS levels were measured spectrophotometrically; Ox-LDL levels were determined by ELISA; ApoA1levels were determined immunoturbidometrically; and TC, TG, and HDL-C levels were determined enzymatically.Results: In the study we observed that PON1 activity decreases when the number of affected vessels increases (r=-0,537, p

Özet

Amaç: Bu çalışmada koroner arter hastalarında damar tıkanıklığının şiddetine bağlı olarak serum Okside LDL (Ox-LDL) konsantrasyonu; son zamanlarda kardiyovasküler risk faktör olarak tanımlanan Paraoksonaz 1 (PON1) aktivitesi ve tiobarbitürik asit reaktif substansları (TBARS) düzeyleri arasındaki olası ilişki araştırıldı. Yöntemler: Okside LDL, Apolipoprotein AI (Apo AI), TBARS düzeyleri, PON1 aktivitesi lipid profili (Total Kolesterol (TK), Trigliserid (TG), LDL Kolesterol (LDL-K), HDL Kolesterol (HDL-K), VLDL Kolesterol (VLDL-K) düzeyleri 42 koroner arter hastası ve 17 sağlıklı bireyde belirlendi. Hasta grubu anjiografi sonuçlarına göre tek damar (n:13), iki damar (n:15) ve üç damar (n:14) olarak 3 alt gruba bölündü. PONI aktivitesi ve TBARS düzeyleri spektrofotometrik, Ox-LDL düzeyleri Eliza, Apo-AI immunoturbidimetrik, TK, TG ve HDL-K düzeyleri ise enzimatik yöntemlerle tayin edildi. Bulgular: Çalışmamızda damar tıkanıklık derecesi arttıkça PON1 aktivitesinin azaldığı gözlendi (r: -0,537, p

🔖

Cite This Article

BELCE, A., EKMEKÇİ, H., UZUN, H., AYOĞLU, R. U., EKMEKÇİ, Ö. B., AYOĞLU, Ö. B. (2022). Paraoxonase Activity and Oxidized LDL Levels as Cardiovascular Risk Factors in Patients with Coronary Artery Disease. İstanbul Medical Journal, Cilt: 14 - Sayı: 2, 69–75. https://ajindex.com/articles/552294

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Betteridge DJ. What is oxidative stress? Metabolism 2000
  2. [CrossRef] 2. Pandya DP. Oxidant injury in coronary heart disease (Part-I): Compr Ther 2001
  3. [CrossRef] 3. Bonnefont-Rousselot D, Therond P, Beaudeux JL, Peynet J, Legrand A, Delattre J. High density lipoproteins (HDL) and oxidative hypothesis of atherosclerosis. Clin Chem Lab Med 1999
  4. [CrossRef] 4. Holvoet P, Stassen JM, Van Cleemput J, Collen D, Vanhaecke J. Oxidized low density lipoproteins in patients with transplant-associated coronary artery disease. Arterioscler Thromb Vasc Biol 1998
  5. [CrossRef] 5. Holvoet P, Vanhaecke J, Janssens S, Van de Werf F, Collen D. Oxidized LDL andmalondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation 1998
  6. [CrossRef] 6. Costa LG, Vitalone A, Cole TB, Furlong CE. Modulation of paraoxonase (PON1) activity. Biochem Pharmacol 2005
  7. [CrossRef] 7. Watson AD, Berliner JA, Hama SY, La Du BN, Faull KF, Fogelman AM, et al. Protective effect of high density lipoprotein associated paraoxonase: inhibition of the biological activity of minimally oxidized low density lipoprotein. J Clin Invest 1995
  8. [CrossRef] 8. Aviram M, Rosenblat M, Bisgaier CL, Newton RS, Primo-Parmo SL, La Du BN. Paraoxonase inhibits high density lipoprotein oxidation and preserves its function: a possible peroxidative role for paraoxonase. J Clin Invest 1998
  9. [CrossRef] 9. Jaouad L, Guise C, Berrougui H, Cloutier M, Isabelle M, Fulop T, et al. Age-related decrease in high-density lipoproteins antioxidant activity is due to an alteration in the PON1’s free sulfhydyl groups. Atherosclerosis 2006
  10. [CrossRef] 10. Sanghera DK, Saha N, Aston CE, Kamboh MI. Genetic Polymorphism of Paraoxonase and the Risk of Coronary Heart Disease Arteriosclerosis, Thrombosis, and Vascular Biology. 1997
  11. [CrossRef] 11. Austen WG, Edwards JE, Frye RL, Gensini GG, Gott VL, Griffith LS, et al. A reporting system on patients evaluated for coronary artery disease. Circulation 1975
  12. [CrossRef] 12. Greenland P, Smith SC Jr, Grundy SM. Improving coronary heart disease assessment in asymptomatic people. Role of traditional risk factors and noninvasive cardiovascular tests. Circulation 2001
  13. [CrossRef] 13. Angel MF, Ramasastry SS, Swartz WM, Narayanan K, Kuhns DB, Basford RE, et al. The critical relationship between free radicals